Mumbai: According to recent research, the global market for Parkinson’s disease (PD) treatments is expected to grow significantly, reaching $7.9 billion by 2033, up from $3.4 billion in 2023. The expansion is primarily driven by advancements in treatment options and the increasing prevalence of the disease due to aging populations. A study by data and analytics firm GlobalData highlights that the seven major markets—the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan—will witness the most substantial growth, with a projected compound annual growth rate (CAGR) of 8.9%…
Read More